AGP Picks
View all

AGP Executive Report

Your go-to archive of top headlines, summarized for quick and easy reading.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

Pharma Deal: Hungary’s Gedeon Richter agreed to buy Australia’s Mayne Pharma for about A$604 million, a move it says will expand its reach in women’s health. AI in Care: Apple and OpenEvidence are studying how people use AI for health advice, as scrutiny grows over the safety and reliability of these tools. Patient Data: A new international charter calls for people with diabetes to have more control over data from glucose monitors and insulin devices. Public Health: The U.S. has lost measles-elimination status after the virus resumed regular transmission, underscoring the risks of falling vaccination rates. Alzheimer’s Treatment: Five-year data from lecanemab’s extension study suggest continued treatment may help patients stay longer in early disease stages. MedTech: Medtronic plans to acquire Contego Medical for $380 million, expanding its vascular-device portfolio.

AI and Care: Apple has launched a U.S. study app for health questions, using medical research and, with permission, users’ health data. The company says it will assess whether answers are clear and useful; it is a research tool, not a doctor. Cancer Detection: OrisDX says its saliva DNA test for suspicious oral lesions showed 94% sensitivity and 98% specificity. The test is available through dental and medical providers, including for at-home use. Rural Access: Houston Methodist is extending remote inpatient monitoring to rural Kansas hospitals, where its clinicians will review vital-sign data and coordinate with bedside teams. Public Health: The U.S. has lost its measles-elimination status after ongoing transmission. Two vaccine doses prevent about 97% of infections, but more than 8,000 people have been sickened in recent outbreaks. Prevention: Alpro Pharmacy and Diabetes Malaysia conducted 11,007 free blood-glucose screenings in 48 hours, aiming to make early detection more accessible.

India Health Spending: Government health spending has more than tripled in a decade to ₹4.14 lakh crore, while households’ share of costs fell to 42.7%. But spending remains below its 2021–22 peak, and families still pay a large share directly. Pollution and Insurance: Pollution-linked health insurance claims in India rose 4.34 times in three years, with heart and respiratory conditions making up most claims. Health AI: Apple and OpenEvidence launched a study inviting up to 200,000 US adults to test an experimental health chat app and rate its answers for accuracy and relevance. Epilepsy Treatment: Morocco’s first locally made cannabis-based medicine for drug-resistant epilepsy has reached pharmacies after a five-year, $20 million development effort; the company plans exports. Surgical Robotics: Samsung Medical Center has performed 109 robot-assisted epilepsy surgeries, using robotic guidance to place electrodes that help locate seizure origins. Primary Care: Irish company Cora Medical is opening clinics and offering salaried roles to attract doctors home, aiming to ease GP shortages and improve access to appointments.

Public Health: The U.S. has lost its measles-elimination status after sustained transmission, according to global health authorities. Two doses of the MMR vaccine prevent about 97% of infections. Pharma Investment: Eli Lilly is eyeing a $1 billion investment in Hyderabad, as India courts global drugmakers. Healthcare Costs: India’s government health spending more than tripled to ₹4.14 lakh crore in 2023–24, while households’ share of costs paid out of pocket fell to 42.7%, down from 64.2% a decade earlier. GLP-1 Care: Cleveland Clinic researchers found patients who stopped weight-loss injections did better when they moved to another treatment; those receiving no further care had the least weight loss and improvement in blood sugar and blood pressure. The FDA is also requiring updated safety information on semaglutide medicines after a potential link to a rare vision condition. Early Intervention: AC Health is backing a Valenzuela program offering developmental support for children from birth to age five.

Public Health: The U.S. has lost measles elimination status after the virus resumed regular transmission, according to global health authorities; a formal announcement is expected Nov. 17. More than 8,000 people have been infected in U.S. outbreaks over two years. Pharma Oversight: Telangana regulators seized ₹3.54 lakh worth of pharmaceutical ingredients allegedly stored for sale without a license at a company in the state’s Medical Devices Park. Drug Development: Amylyx Pharmaceuticals says its Phase 3 trial of avexitide cut hypoglycemic events by 55% among patients with post-bariatric hypoglycemia, a potential step toward addressing a treatment gap. Health Data: A breach at Fullerton Health exposed records for about 140,000 migrant workers. Digital Resilience: Microsoft says its global outage is resolved after disrupting services used by healthcare organizations, including the U.K.’s NHS.

Cancer Care: China will add its first CAR-T therapy to basic medical insurance from Jan. 1, 2027, potentially easing the cost of a treatment once priced above 1 million yuan. Drug Manufacturing: Eli Lilly broke ground on a $3.5 billion Pennsylvania plant, backed by $100 million in state support, with at least 850 permanent jobs planned. Insurance Costs: A Michigan cancer survivor’s ACA premium is set to climb from $313 a month to $1,181 in two years after enhanced subsidies expired, putting coverage out of reach for some middle-income patients. Mental Health Coverage: Insurers often treat a history of mental illness as a reason to raise premiums or limit life insurance, even as mental health conditions drive disability claims. Data Security: Fullerton Health says records for about 140,000 migrant workers were exposed in a breach; it reports no health, medical or financial details were compromised. Global Health Funding: The Trump administration plans to divert or withhold nearly all $605 million Congress approved for overseas family planning, while proposing cuts to health aid for poorer countries.

Health-System Resilience: Microsoft’s global outage disrupted hospitals, pharmacies and other services, exposing their reliance on a few cloud providers; NHS trusts reported problems and prescription delays. Drug Manufacturing: Eli Lilly has begun work on a $3.5 billion Pennsylvania plant for GLP-1 medicines, with about 850 permanent jobs expected. Insurance Oversight: California has barred Astiva Health from enrolling new Medicare Advantage members after it failed to meet required financial reserves; current coverage remains in place. Public Health: U.S. measles cases have topped 5,400, with new deaths reported in Wisconsin and Pennsylvania. Rural Care: Michigan announced $6.43 million in grants for technology projects to improve care coordination and access in rural communities. AI and Mental Health: Experts warn chatbots can give inaccurate advice and should not be used to diagnose or treat mental health conditions.

Digital Disruption: Microsoft’s global outage disrupted health services, including GPs and pharmacies, as well as business communications. The company attributed the disruption to server problems and said it had found no signs of malicious activity. Drug Manufacturing: Ghana’s National Vaccine Institute says unpredictable demand is deterring investment in local pharmaceutical production. Regional pooled purchasing could help guarantee orders and unlock financing. Radiopharma Growth: PharmaLogic agreed to buy Lantheus’ New Jersey radiopharmaceutical manufacturing business, expanding capacity for developing and producing targeted cancer treatments. Vaccine Market: Bavarian Nordic beat third-quarter revenue forecasts, citing strong travel-health sales, led by rabies vaccines and supported by its chikungunya vaccine launch. Cancer Research: Silexion Therapeutics dosed the first patient in a Phase 2/3 trial of its experimental pancreatic cancer therapy. Hospital Deal: St. Luke’s Hospital signed a letter of intent to join BJC Health; financial terms and the deal timeline have not been disclosed.

Health Plan Costs: Open enrollment is underway as 2027 premiums rise; shoppers are urged to compare costs, covered doctors and prescriptions before renewing. Hospital Safety: Scotland’s inquiry into Glasgow hospital infections has finished hearing witnesses, with findings expected soon. Seven deaths are under investigation. AI in Practice: A survey found 63% of physicians use AI for clinical decision support, up from 37% last year; many also worry about its effect on trainee skills. Specialty Drug Access: Lehigh Valley Hospital Pharmacy is suing Highmark, alleging the insurer steers patients to a competitor it owns. Highmark says it will respond in court. Pharma Investment: Ghana plans to invest $1 billion in local drug and biomanufacturing, aiming to reduce imports that account for up to 75% of its medicine supply. Pfizer and Blackstone also struck a deal worth up to $1.5 billion to fund GLP-1 drug trials. Rural Care: Vermont will receive nearly $190 million in a second year of federal rural health funding, supporting technology upgrades, workforce training and primary care.

Coverage Costs: ACA open enrollment is underway as health insurance premiums rise for 2027, putting affordability in focus. Maternal Health: Elevance Health Foundation is giving Healthy Birth Day $1.3 million to expand stillbirth-prevention education and provider training across 11 states. Care Access: Cleveland Clinic has acquired Youngstown Orthopaedic Associates and is adding a coordinated outpatient surgery, imaging and therapy network. In Waukegan, ambulance crews are bypassing Vista Medical Center East, lengthening emergency trips as local leaders press its owner to sell. Industry Investment: Autocam Medical opened a $70 million Warsaw plant and expects to add 250 to 300 jobs as production ramps up. Drug Development: Immuneering and Astellas will collaborate on trials of investigational combination treatments for pancreatic cancer.

Coverage Costs: ACA marketplace premiums are projected to rise 13% in 2027, with the end of enhanced federal tax credits adding pressure for many shoppers. Some states are offering their own subsidies, while insurers are exiting certain markets. Preventive Care: Get A Drip founder Richard Chambers and GP Luke Pratsides plan to open Ohas, a £1.5 million London clinic offering a £295 health assessment and follow-up care from January. Rural Access: Arkansas received another $207.7 million in federal rural health funding, while Vermont’s Johnson Health clinic is moving to a larger space to expand primary and substance-use care after flood-related disruption. Digital Health: Oura is buying AI primary-care startup Counsel Health for $625 million, extending its push from wearable tracking into care. Patient Privacy: CHIME and 17 health organizations are urging HHS not to limit providers’ ability to verify patient authorization before third-party apps access medical records. Sunbed Claims: UK advertisers have until Dec. 7 to remove claims that sunbeds are safe or treat health conditions; regulators warn UV exposure raises skin-cancer risk.

Digital Care: Oura will acquire AI primary-care company Counsel Health for $625 million, combining wearable data with AI guidance and access to physicians. Regional Health: BIMSTEC ministers adopted a 2026–30 public-health plan covering disease surveillance, pandemic readiness and digital health; India also pledged ambulances and health kiosks for Sri Lanka. Hospital Technology: Akara raised $5.5 million for AI tools that track hospital space use and help coordinate staff. Drug Manufacturing: PharmaLogic agreed to buy Lantheus’ radiopharmaceutical manufacturing business and New Jersey facility, expanding capacity for targeted therapies. Medicine Access: NRx has begun selling U.S.-made preservative-free ketamine amid a shortage dating to 2018, with shipments planned for January. Pharmacy Pressures: Williams Brothers will close its Vincennes retail pharmacy, citing reimbursement rates that fail to cover dispensing costs; its medical equipment business will remain open.

Physician Workforce: CMS distributed 200 new Medicare-supported residency positions, a step toward addressing a projected U.S. shortage of up to 86,000 doctors by 2036. Digital Health: Oura agreed to buy AI primary-care startup Counsel Health for $625 million, while Google introduced Gemini for Healthcare as hospitals explore AI tools to improve care and costs. Biotech Advances: PepGen shares jumped after early Phase 2 results for its muscular dystrophy drug showed improved muscle function in a small patient group. Inovio, meanwhile, secured accelerated FDA approval for VOCERYQ, which it calls the first approved DNA medicine, and plans a commercial launch in early 2027. Research Funding: Medical school leaders say NIH grant disruptions have weakened lab morale and trust in funding, prompting researchers to seek new ways to support their work. Rural Care: CMS released a second year of rural health transformation awards, distributing $10 billion to states to strengthen access and services.

Rural Health Funding: The federal government is distributing $10 billion to states for a second year of rural health grants, supporting efforts to expand access and strengthen care. Healthcare AI: Google launched Gemini for Healthcare, which can pull records together, help review prior authorizations and check insurance coverage; Northwell, HCA Healthcare and other systems are among its launch customers. Drug Access: The Access to Medicine Foundation warns that pharma companies’ focus on weight-loss drugs could divert attention from insulin, which remains out of reach for many people with diabetes. Health Data: WHO says African countries have improved their ability to collect health information but still struggle to turn it into policy and better services; the region scored 59 out of 100 on health information system maturity. Digital Accessibility: A new service aims to help healthcare providers meet HHS requirements for accessible websites and apps, with the first compliance deadline in May 2027. Biomanufacturing: Curia invested €5 million in a precision fermentation facility in Spain, raising the site’s capacity to 58,000 litres for biotech development and production.

Rural Care: States are receiving large second-year federal rural health awards, including $225.9 million for Kansas and nearly $190 million for Vermont, to strengthen access, staffing and technology. AI Imaging: South Korea’s Lunit will supply chest X-ray and mammography analysis software to Saudi Arabia’s National Guard Health Affairs, integrated with its existing imaging system. Stroke Prevention: The FDA approved the first Factor XIa inhibitor to help prevent stroke in certain high-risk adults. Biotech: Ionis shares fell about 25% after the company cut its 2026 sales forecast for triglyceride-lowering drug Tryngolza to $50 million, from $100 million to $110 million. Caregiver Tech: Avanlee Care raised $3.5 million to help Medicare Advantage plans connect family caregivers with care coordination, medication and wellness support.

Health Insurance: India’s regulator approved HDFC Mutual Fund raising its stake in Star Health to 9.99%, from 4.49%. Community Care: Penn’s $5.5 million NIH-backed partnership with Philadelphia health workers has reached more than 150 residents, pairing chronic heart-care support with help accessing food, housing, transport and insurance. Cancer Access: India cut prices on 1,364 anti-cancer formulations, with reported savings for patients of Rs 3,540 crore a year. Onsite Healthcare: OneVeracity and Vigilant Health are joining forces to expand employer health centers, connecting clinical care with navigation and population-health services. Drug Pipeline: The FDA accepted Celcuity’s application for REVTORPYK in advanced breast cancer; the agency’s decision target is June 25, 2027. Health System Technology: R1 and Ascension extended their partnership through 2037 to advance technology-led revenue-cycle operations. Corporate Restructuring: CVS plans to split into two publicly traded companies by 2028.

AI and Maternal Care: Google.org awarded Nigerian health-tech company Helium Health $2.5 million to deploy clinical AI in primary maternal care. The project aims to reach 1.9 million more women over three years. Cancer Pipeline: InnoCare dosed the first patient in a Phase III trial comparing its leukemia drug mesutoclax with venetoclax in combination with azacitidine. Medical Tourism: Apollo Hospitals’ Sangita Reddy says global insurance coverage for treatment in India could draw more international patients and accelerate growth. Manufacturing and Market Moves: Pakistan’s Getz Pharma secured WHO prequalification for a second facility, supporting its export ambitions. Pfizer plans to invest $650 million in a manufacturing technology center, while CVS intends to split into two publicly traded companies by 2028. Vaccine Access: Health Canada approved Moderna’s mRNA flu and combined flu-COVID vaccines.

Health Tourism: Vietnam is considering special visas for remote workers and international patients, including people seeking treatment, rehabilitation or longer-term care, to attract higher-spending visitors. Medicine Safety: Qatar recalled all shipments of Ferinject, an IV treatment for iron-deficiency anemia, after tests found it did not meet the manufacturer’s chemical specifications. Pharma Supply: Indian drugmakers want clarity on new batch-by-batch clearance rules for high-risk solvents, warning that uncertainty could disrupt medicine production and exports. Health Innovation: An Arab-China forum opened in Cairo with health security, AI and medical supply chains on the agenda. Separately, University of Michigan cardiologists outlined safeguards for one-time gene edits aimed at common heart conditions, citing permanent effects, rare risks and high costs. Coverage Costs: Employer coverage of GLP-1 drugs for obesity fell to 33% in 2026 from 43% a year earlier, leaving some patients facing steep out-of-pocket costs.

CVS Restructuring: CVS Health plans to split into two publicly traded companies by 2028, separating its pharmacy business from insurance. Heart Research: Cleveland Clinic’s phase 3 trial found pelacarsen lowered Lp(a) but did not reduce major cardiovascular events over nearly five years. In an early human trial, a gene-silencing drug lowered LDL and triglycerides and was generally well tolerated. Drug Quality: Reports say the US FDA flagged data-integrity violations at Indian pharmaceutical facilities, putting manufacturing oversight in focus. Care Technology: Newcastle’s NHS surgical training centre received nearly £8 million to become a national hub for training and expanding the use of surgical robots. Pharmacy Access: US data show more than 3,000 pharmacies closed between 2022 and 2024, mostly chains, highlighting continued pressure on access to medicines.

Pharmacy Operations: Walgreens opened a robotic prescription hub in Pennsylvania expected to fill nearly 29 million prescriptions a year for about 650 stores, adding 185 jobs and potentially freeing store pharmacists for more patient care. Industry Restructuring: CVS plans to split into two public companies by 2028, separating its healthcare-solutions business from retail pharmacy and community care. Youth Mental Health: Oregon has updated its online “Crisis to Care” guide, helping families navigate behavioral health emergencies and find support such as 988. Drug Manufacturing: Oman is advancing three projects in Sohar to make pharmaceutical ingredients and antibiotic materials, aiming to strengthen medicine security and exports. Research Partnerships: India and the EU have finalized India’s association with Horizon Europe, opening access to joint research funding and collaboration in health and other fields. Global Health: Experts warn that new U.S. aid agreements could weaken pandemic readiness, including plans to end funding for health workers in Congo amid an Ebola outbreak.

Sign up for:

Health Industry Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Industry Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.